Proceedings of the 41st Annual General Meeting of the Company held on September 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medico Intercontinental Ltd held its 41st AGM on September 30, 2025, via video conferencing, chaired by Mr. Samir Shah. Members approved the audited financial statements (standalone and consolidated) for FY ended March 31, 2025, and re-appointed Mrs. Tanvi Samirbhai Shah as a director (retiring by rotation). They also appointed M/s. Agarwal & Mehta, Company Secretaries LLP as the Secretarial Auditor for a 5-year term (FY2025-26 to FY2029-30). Key approvals included a sharp increase in borrowing limits from Rs. 20 crore to Rs. 100 crore (a 5x jump), creation of charges on company assets, higher remuneration for Managing Director Mr. Samir Shah, expanded Section 185/186 limits for loans, investments and guarantees, and approval for related party transactions. E-voting was conducted via CDSL between September 27-29, 2025, with results to be declared within two working days.
The 5x increase in borrowing limit (Rs. 20 cr to Rs. 100 cr) and approval for related party transactions suggest the company may be gearing up for major expansion, acquisitions, or higher debt-funded activity, which shareholders should monitor closely. Higher MD remuneration and expanded inter-corporate loan/investment limits also signal potential capital deployment that could affect future earnings and risk profile.